Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...
Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...
Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks ...
Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...
7d
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...
they are growing in popularity to treat patients in need of significant weight loss. That’s because the drugs also send the brain a signal that reduces hunger. Due to their high list price in the ...
On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...
emphasizing their benefits when used under prescription. The MHRA collaborates with social media platforms, law enforcement, and border officials to tackle illegal sellers of weight-loss drugs Get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback